Galantamine Causes Weight Loss and Improves Glycemic Control in Diabetic Mice

Obesity-related inflammation contributes to the pathogenesis of type 2 diabetes mellitus (T2DM). Galantamine activates the vagal-mediated cholinergic anti-inflammatory pathway (CAP). We hypothesize that galantamine will decrease food intake, body weight and improve glycemic control in the obese (db/db) mouse model.
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Tags: Bariatric and foregut Source Type: research